The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A cost-utility analysis of atezolizumab in the second-line treatment of metastatic urothelial carcinoma.
 
Ambika Parmar
No Relationships to Disclose
 
Marina Richardson
No Relationships to Disclose
 
Beate Sander
No Relationships to Disclose
 
Susanna Y. Cheng
Honoraria - AstraZeneca; Merck; Roche Canada
Consulting or Advisory Role - AstraZeneca; Merck
 
Kelvin K. Chan
No Relationships to Disclose